Clinical factors affecting the long-term survival of breast cancer patients

被引:3
作者
Li, Yong-Hui [1 ,2 ]
Wang, Xiao-Ying [3 ]
Shen, Jun-Wei [1 ]
Ma, Lin-Lin [1 ]
Wang, Cui-Ping [1 ]
He, Kai [3 ]
Liu, Ding-Sheng [4 ]
Li, Yan-Fei [1 ,5 ]
机构
[1] Shanghai Univ Med & Hlth Sci, Affiliated Zhoupu Hosp, Shanghai, Peoples R China
[2] Luoyang Normal Univ, Luoyang, Henan, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Shanghai, Peoples R China
[4] Shanghai Pudong New Area Gongli Hosp, Shanghai, Peoples R China
[5] Shanghai Univ Med & Hlth Sci, 279 Zhouzhu Rd, Shanghai 201318, Peoples R China
关键词
Breast cancer; long-term survival; estrogen receptor; progesterone receptor; breast-conserving surgery; Nottingham prognostic index; NOTTINGHAM PROGNOSTIC INDEX; THERAPY; STATISTICS; RECURRENCE; PROGRESS; FUTURE; STAGE;
D O I
10.1177/03000605231164004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
ObjectiveThe average 5-year survival rate of breast cancer (BC) patients has been significantly prolonged with new therapeutic methods. However, their effects on BC patient long-term survival rates are unclear. Therefore, this study aimed to analyze the specific clinical factors that can affect BC long-term survival. MethodsHere, we conducted a retrospective study and analyzed long-term survival using data of 3,240 BC patients from 1977 to 2005 from the Genotype-Tissue Expression (GTEx) database using the Kaplan-Meier method. ResultsBreast tumor size and stage were negatively correlated with long-term survival, but age showed no significant correlation. Estrogen receptor (ER) and progesterone receptor (PR) expression were each positively correlated with patient survival time, while ERBB2 receptor (HER2) expression was negatively correlated with survival time. Patients with high Nottingham prognostic index (NPI) values did not benefit from available therapies. Furthermore, breast-conserving surgery is more conducive to BC patient long-term survival than mastectomy. ConclusionsEarly detection and breast-conserving surgery may support long-term survival for BC patients. Elevated expression of ER and PR were both associated with longer patient survival time, while positive expression of HER2 showed the opposite trend. The long-term survival rates of patients with high NPI values can potentially be increased.
引用
收藏
页数:10
相关论文
共 41 条
[1]  
Al jarroudi O, 2019, Asian Pac J Cancer Prev, V20, P59
[2]   Shift work and the incidence of prostate cancer: a 10-year follow-up of a German population-based cohort study [J].
Behrens, Thomas ;
Rabstein, Sylvia ;
Wichert, Katharina ;
Erbel, Raimund ;
Eisele, Lewin ;
Arendt, Marina ;
Dragano, Nico ;
Bruening, Thomas ;
Joeckel, Karl-Heinz .
SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 2017, 43 (06) :560-568
[3]   Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05) [J].
Blok, Erik J. ;
Kroep, Judith R. ;
Kranenbarg, Elma Meershoek-Klein ;
Duijm-de Carpentier, Marjolijn ;
Putter, Hein ;
van den Bosch, Joan ;
Maartense, Eduard ;
van Leeuwen-Stok, A. Elise ;
Liefers, Gerrit-Jan ;
Nortier, Johan W. R. ;
Rutgers, Emiel J. Th. ;
van de Velde, Cornelis J. H. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (01) :40-48
[4]  
Blumen H, 2016, AM HEALTH DRUG BENEF, V9, P23
[5]   Optimizing treatment in recurrent epithelial ovarian cancer [J].
Corrado, Giacomo ;
Salutari, Vanda ;
Palluzzi, Eleonora ;
Distefano, Maria Grazia ;
Scambia, Giovanni ;
Ferrandina, Gabriella .
EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (12) :1147-1158
[6]   Advances in ovarian cancer therapy [J].
Cortez, Alexander J. ;
Tudrej, Patrycja ;
Kujawa, Katarzyna A. ;
Lisowska, Katarzyna M. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) :17-38
[7]   Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy [J].
Degerli, Ezgi ;
Oztas, Nihan Senturk ;
Alkan, Gulin ;
Bedir, Sahin ;
Derin, Sumeyra ;
Valikhanova, Nahida ;
Sarac, Betul ;
Kacar, Ezgi ;
Demirci, Nebi Serkan ;
Demirelli, Hulusi Fuat ;
Turna, Hande .
JOURNAL OF CHEMOTHERAPY, 2023, 35 (01) :29-38
[8]   Breast cancer statistics, 2017, racial disparity in mortality by state [J].
DeSantis, Carol E. ;
Ma, Jiemin ;
Sauer, Ann Goding ;
Newman, Lisa A. ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (06) :439-448
[9]   Breast Cancer Statistics, 2015: Convergence of Incidence Rates Between Black and White Women [J].
DeSantis, Carol E. ;
Fedewa, Stacey A. ;
Sauer, Ann Goding ;
Kramer, Joan L. ;
Smith, Robert A. ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (01) :31-42
[10]   Targeting EGFR in Lung Cancer: Current Standards and Developments [J].
Diaz-Serrano, Asuncin ;
Gella, Pablo ;
Jimenez, Elisabeth ;
Zugazagoitia, Jon ;
Paz-Ares Rodriguez, Luis .
DRUGS, 2018, 78 (09) :893-911